{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:23:59Z","timestamp":1790742239335,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Combination of different first-line treatments for erectile dysfunction (ED) has emerged as a promising therapeutic approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To conduct the first double-blind, randomized, placebo-controlled clinical trial to evaluate the efficacy and safety of combination therapy with low-intensity shockwave therapy (LiST) and tadalafil vs LiST and placebo in patients with mild or mild-to-moderate vasculogenic ED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fifty sexually active patients fulfilling the eligibility criteria were randomly assigned to 6 sessions of LiST twice weekly for 3 weeks and tadalafil (n = 25) or placebo (n = 25) once daily for 4 weeks. Patients were evaluated at 1, 3, and 6 months after completion of the treatment protocol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>The primary outcome was the mean change from baseline in the International Index of Erectile Function-Erectile Function (IIEF-EF) domain between the 2 groups at 3 months after treatment. Erectile function was also assessed at 1 and 6 months. The number of patients attaining a minimal clinically important difference (MCID) in the IIEF-EF, as well as the safety of combination therapy were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Adjusting for the baseline values, IIEF-EF improved by 0.8 points more (95% confidence interval [CI] = \u22120.2 to 1.9, P = .12) at 1 month, 1 point more (95% CI = 0.1\u20131.9, P = .02) at 3 months and 1.7 points more (95% CI = 0.8\u20132.7, P &amp;lt; .001) at 6 months in patients treated with combination therapy compared to monotherapy. The number of patients attaining a MCID in the IIEF-EF between the 2 groups improved significantly only at the 3-month evaluation. No adverse events were reported during the whole study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Implications<\/jats:title>\n                    <jats:p>Combination of LiST twice weekly for 3 weeks and tadalafil 5 mg once daily for 4 weeks may further ameliorate mild or mild-to-moderate vasculogenic ED compared to LiST monotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Strengths &amp; Limitations<\/jats:title>\n                    <jats:p>We conducted the first randomized trial exploring the role of LiST and tadalafil in the management of ED. Conversely, our study lacks external validity due to its single-center design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The addition of daily low-dose tadalafil during application of LiST may further improve erectile function compared to application of LiST as a standalone treatment in patients with mild or mild-to-moderate vasculogenic ED. Still, further high-quality studies are warranted to corroborate our findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.jsxm.2021.10.007","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T09:47:00Z","timestamp":1638438420000},"page":"106-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Effect of Combination Treatment with Low-Intensity Shockwave Therapy and Tadalafil on Mild and Mild-To-Moderate Erectile Dysfunction: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial"],"prefix":"10.1093","volume":"19","author":[{"given":"Ioannis","family":"Mykoniatis","sequence":"first","affiliation":[{"name":"First Department of Urology, G. Gennimatas Hospital, Aristotle University of Thessaloniki , Thessaloniki , Greece"},{"name":"Institute for the Study of Urological Diseases , Thessaloniki , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Pyrgidis","sequence":"additional","affiliation":[{"name":"Institute for the Study of Urological Diseases , Thessaloniki , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filimon","family":"Zilotis","sequence":"additional","affiliation":[{"name":"First Department of Urology, G. Gennimatas Hospital, Aristotle University of Thessaloniki , Thessaloniki , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskeui","family":"Kapoteli","sequence":"additional","affiliation":[{"name":"First Department of Urology, G. Gennimatas Hospital, Aristotle University of Thessaloniki , Thessaloniki , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agrippina","family":"Fournaraki","sequence":"additional","affiliation":[{"name":"First Department of Urology, G. Gennimatas Hospital, Aristotle University of Thessaloniki , Thessaloniki , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kalyvianakis","sequence":"additional","affiliation":[{"name":"First Department of Urology, G. Gennimatas Hospital, Aristotle University of Thessaloniki , Thessaloniki , Greece"},{"name":"Institute for the Study of Urological Diseases , Thessaloniki , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Hatzichristou","sequence":"additional","affiliation":[{"name":"First Department of Urology, G. Gennimatas Hospital, Aristotle University of Thessaloniki , Thessaloniki , Greece"},{"name":"Institute for the Study of Urological Diseases , Thessaloniki , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jsxm.2020.10.012","article-title":"Prevalence of erectile dysfunction in patients with end-stage renal disease: A systematic review and meta-analysis","volume":"18","author":"Pyrgidis","year":"2021","journal-title":"J Sex Med"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.jsxm.2021.02.008","article-title":"Sexual dysfunction in women with end-stage renal disease: A systematic review and meta-analysis","volume":"18","author":"Pyrgidis","year":"2021","journal-title":"J Sex Med"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psychosocial correlates: Results of the Massachusetts male aging study","volume":"151","author":"Feldman","year":"1994","journal-title":"J Urol"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41443-019-0117-z","article-title":"Clinical studies on low intensity extracorporeal shockwave therapy for erectile dysfunction: A systematic review and meta-analysis of randomised controlled trials","volume":"31","author":"Sokolakis","year":"2019","journal-title":"Int J Impot Res"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jsxm.2018.12.016","article-title":"The basic science behind low-intensity extracorporeal shockwave therapy for erectile dysfunction: A systematic scoping review of pre-clinical studies","volume":"16","author":"Sokolakis","year":"2019","journal-title":"J Sex Med"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1743-6109.2006.00208.x","article-title":"Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat","volume":"3","author":"Vignozzi","year":"2006","journal-title":"J Sex Med"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/j.1743-6109.2010.02152.x","article-title":"Exposure to phosphodiesterase type 5 inhibitors stimulates aromatase expression in human adipocytes in vitro","volume":"8","author":"Aversa","year":"2011","journal-title":"J Sex Med"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.735708","article-title":"The effect of phosphodiesterase-type 5 inhibitors on erectile function: An overview of systematic reviews","volume":"12","author":"Pyrgidis","year":"2021","journal-title":"Front Pharmacol"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-047396","article-title":"Effect of phosphodiesterase-type 5 inhibitors on erectile function: An overview of systematic reviews and meta-analyses","volume":"11","author":"Pyrgidis","year":"2021","journal-title":"BMJ Open"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1007\/s00345-020-03373-y","article-title":"Penile low intensity shock wave treatment for PDE5I refractory erectile dysfunction: A randomized double-blind sham-controlled clinical trial","volume":"39","author":"Vinay","year":"2021","journal-title":"World J Urol"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.juro.2015.12.049","article-title":"Penile low intensity shock wave treatment is able to shift PDE5i nonresponders to responders: A double-blind, sham controlled study","volume":"195","author":"Kitrey","year":"2016","journal-title":"J Urol"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrurol.2017.119","article-title":"Low-intensity shockwave therapy for erectile dysfunction: Is the evidence strong enough?","volume":"14","author":"Young Academic Urologists Men\u2019s Health Group","year":"2017","journal-title":"Nat Rev Urol"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.sxmr.2018.11.007","article-title":"Systematic review of oral combination therapy for erectile dysfunction when phosphodiesterase type 5 inhibitor monotherapy fails","volume":"7","author":"Munk","year":"2019","journal-title":"Sex Med Rev"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.eururo.2021.06.007","article-title":"European Association of Urology guidelines on sexual and reproductive health\u20142021 update: Male sexual dysfunction","volume":"80","author":"Salonia","year":"2021","journal-title":"Eur Urol"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jsxm.2016.08.016","article-title":"Standards for clinical trials in male and female sexual dysfunction: III. Unique aspects of clinical trials in male sexual dysfunction","volume":"14","author":"Fisher","year":"2017","journal-title":"J Sex Med"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jsxm.2018.01.003","article-title":"Low-intensity shockwave therapy for erectile dysfunction: A randomized clinical trial comparing 2 treatment protocols and the impact of repeating treatment","volume":"15","author":"Kalyvianakis","year":"2018","journal-title":"J Sex Med"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.eururo.2011.07.053","article-title":"Minimal clinically important differences in the erectile function domain of the international index of erectile function scale","volume":"60","author":"Rosen","year":"2011","journal-title":"Eur Urol"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.juro.2011.12.117","article-title":"Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study","volume":"187","author":"Vardi","year":"2012","journal-title":"J Urol"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.eururo.2016.05.050","article-title":"Low-intensity extracorporeal shock wave treatment improves erectile function: A systematic review and meta-analysis","volume":"71","author":"Lu","year":"2017","journal-title":"Eur Urol"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.36337","article-title":"Assessment of combination therapies vs monotherapy for erectile dysfunction: A systematic review and meta-analysis","volume":"4","author":"Mykoniatis","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1177\/1557988317721643","article-title":"Low-intensity extracorporeal shockwave therapy can improve erectile function in patients who failed to respond to phosphodiesterase type 5 inhibitors","volume":"11","author":"Tsai","year":"2017","journal-title":"Am J Mens Health"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41443-020-0332-7","article-title":"Low intensity shockwave therapy in combination with phosphodiesterase-5 inhibitors is an effective and safe treatment option in patients with vasculogenic ED who are PDE5i non-responders: A multicenter single-arm clinical trial","volume":"33","author":"Palmieri","year":"2020","journal-title":"Int J Impot Res"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jsxm.2017.05.012","article-title":"Low-intensity shockwave therapy improves hemodynamic parameters in patients with vasculogenic erectile dysfunction: A triplex ultrasonography-based sham-controlled trial","volume":"14","author":"Kalyvianakis","year":"2017","journal-title":"J Sex Med"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41443-019-0185-0","article-title":"Low-intensity shockwave therapy (LiST) for erectile dysfunction: A randomized clinical trial assessing the impact of energy flux density (EFD) and frequency of sessions","volume":"32","author":"Kalyvianakis","year":"2020","journal-title":"Int J Impot Res"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jsxm.2019.12.024","article-title":"The role of the low-intensity extracorporeal shockwave therapy on penile rehabilitation after radical prostatectomy: A randomized clinical trial","volume":"17","author":"Baccaglini","year":"2020","journal-title":"J Sex Med"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1365-2605.2011.01226.x","article-title":"Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie\u2019s disease and erectile dysfunction: Results from a prospective randomized trial","volume":"35","author":"Palmieri","year":"2012","journal-title":"Int J Androl"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/sj.ijir.3901513","article-title":"Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: A pilot study","volume":"19","author":"Aversa","year":"2007","journal-title":"Int J Impot Res"},{"key":"2023041407155829300_","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.esxm.2018.11.008","article-title":"Endothelial dysfunction in patients with erectile dysfunction: A double-blind, randomized-control trial using tadalafil","volume":"7","author":"Pattanaik","year":"2019","journal-title":"Sex Med"},{"key":"2023041407155829300_","first-page":"e13296","article-title":"Effect of prolonged treatment with phosphodiesterase-5-inhibitors on endothelial dysfunction in vascular diseases and vascular risk conditions: A systematic review analysis and meta-analysis of randomized double-blind placebo-controlled trials","volume-title":"Int J Clin Pract","author":"D\u2019Andrea","year":"2019"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609521007426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609521007426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/19\/1\/106\/49888880\/jsm_19_1_106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/19\/1\/106\/49888880\/jsm_19_1_106.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T03:50:43Z","timestamp":1681444243000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/19\/1\/106\/6961202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,2]]},"published-print":{"date-parts":[[2022,1,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2021.10.007","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2022,1]]},"published":{"date-parts":[[2021,12,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effect of Combination Treatment With Low-Intensity Shockwave Therapy and Tadalafil on Mild and Mild-To-Moderate Erectile Dysfunction: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2021.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021, International Society of Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}